These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

343 related items for PubMed ID: 21558988

  • 1. Bisphosphonates in breast cancer: antitumor effects.
    Aft R.
    Clin Adv Hematol Oncol; 2011 Apr; 9(4):292-9. PubMed ID: 21558988
    [Abstract] [Full Text] [Related]

  • 2. Should bisphosphonates be utilized in the adjuvant setting for breast cancer?
    Lipton A.
    Breast Cancer Res Treat; 2010 Aug; 122(3):627-36. PubMed ID: 20490653
    [Abstract] [Full Text] [Related]

  • 3. Role of bisphosphonates in prevention and treatment of bone metastases from breast cancer.
    Paterson AH, Kanis JA, Powles TJ, McCloskey E, Hanson J, Ashley S.
    Can J Oncol; 1995 Dec; 5 Suppl 1():54-7. PubMed ID: 8853526
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Bisphosphonates for the prevention of bone metastases.
    Coleman RE.
    Semin Oncol; 2002 Dec; 29(6 Suppl 21):43-9. PubMed ID: 12584694
    [Abstract] [Full Text] [Related]

  • 6. Bisphosphonates: clinical experience.
    Coleman RE.
    Oncologist; 2004 Dec; 9 Suppl 4():14-27. PubMed ID: 15459426
    [Abstract] [Full Text] [Related]

  • 7. New results from the use of bisphosphonates in cancer patients.
    Coleman R, Gnant M.
    Curr Opin Support Palliat Care; 2009 Sep; 3(3):213-8. PubMed ID: 19561507
    [Abstract] [Full Text] [Related]

  • 8. Clinical value of bisphosphonates in cancer therapy.
    Lüftner D, Henschke P, Possinger K.
    Anticancer Res; 2007 Sep; 27(4A):1759-68. PubMed ID: 17649770
    [Abstract] [Full Text] [Related]

  • 9. In vitro and in vivo antiresorptive effects of bisphosphonates in metastatic bone disease.
    Kanakis I, Kousidou OCh, Karamanos NK.
    In Vivo; 2005 Sep; 19(1):311-8. PubMed ID: 15796191
    [Abstract] [Full Text] [Related]

  • 10. Bisphosphonates in breast cancer: clinical activity and implications of preclinical data.
    Aft R.
    Clin Adv Hematol Oncol; 2011 Mar; 9(3):194-205. PubMed ID: 21475125
    [Abstract] [Full Text] [Related]

  • 11. Clinical trials in metastatic breast cancer to bone: past--present--future.
    Body JJ.
    Can J Oncol; 1995 Dec; 5 Suppl 1():16-27. PubMed ID: 8853520
    [Abstract] [Full Text] [Related]

  • 12. Bisphosphonates in breast cancer patients with skeletal metastases.
    Shapiro CL.
    Hematol Oncol Clin North Am; 1994 Feb; 8(1):153-63. PubMed ID: 8150777
    [Abstract] [Full Text] [Related]

  • 13. Bisphosphonates for cancer patients: why, how, and when?
    Body JJ, Mancini I.
    Support Care Cancer; 2002 Jul; 10(5):399-407. PubMed ID: 12136223
    [Abstract] [Full Text] [Related]

  • 14. Approval summary for zoledronic acid for treatment of multiple myeloma and cancer bone metastases.
    Ibrahim A, Scher N, Williams G, Sridhara R, Li N, Chen G, Leighton J, Booth B, Gobburu JV, Rahman A, Hsieh Y, Wood R, Vause D, Pazdur R.
    Clin Cancer Res; 2003 Jul; 9(7):2394-9. PubMed ID: 12855610
    [Abstract] [Full Text] [Related]

  • 15. Bisphosphonates: ready for use as adjuvant therapy of breast cancer?
    Theriault RL.
    Curr Opin Obstet Gynecol; 2010 Feb; 22(1):61-6. PubMed ID: 19934757
    [Abstract] [Full Text] [Related]

  • 16. [Current use of bisphosphonates in clinical oncology].
    Vrbanec D, Plestina S, Belev B, Unusić J, Pavlinić-Diminić V.
    Lijec Vjesn; 1999 Feb; 121(9-10):296-301. PubMed ID: 19658372
    [Abstract] [Full Text] [Related]

  • 17. The role of bisphosphonates in breast cancer.
    Coleman RE.
    Breast; 2004 Dec; 13 Suppl 1():S19-28. PubMed ID: 15585379
    [Abstract] [Full Text] [Related]

  • 18. Bisphosphonates and their impact on disseminated tumor cells in early stage breast cancer.
    Li J, Rugo HS.
    Breast Dis; 2011 Dec; 33(2):83-92. PubMed ID: 22142661
    [Abstract] [Full Text] [Related]

  • 19. Bisphosphonates and breast cancer incidence and recurrence.
    Chlebowski RT, Col N.
    Breast Dis; 2011 Dec; 33(2):93-101. PubMed ID: 22142660
    [Abstract] [Full Text] [Related]

  • 20. Emerging strategies in bone health management for the adjuvant patient.
    Coleman RE.
    Semin Oncol; 2007 Dec; 34(6 Suppl 4):S11-6. PubMed ID: 18068485
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.